TQB3616 Capsules in the Treatment of Dedifferentiated Liposarcoma
Stopped This study was closed due to business reasons. Closure was not prompted by any safety or efficacy concerns.
Conditions
- Dedifferentiated Liposarcoma
Interventions
- DRUG: TQB3616 capsule
- DRUG: TQB3616 placebo
Sponsor
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.